However, central inhibition of IKK2 with IMD-0354 did show protective effect on the PM2.5-induced peripheral inflammation and metabolic disorder, including O2 consumption, CO2 production, heat production, glucose tolerance, and insulin sensitivity (Liu et al., 2014a,b). This evidence concerns the gene INS and metabolic disease.